Preoperative exclusive enteral nutrition ameliorates CRP-to-albumin ratio without affecting body mass index in Crohn’s disease
Authors:
Open Access
- 29 May 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1780773
Abstract
Background: Crohn’s disease (CD) frequently exhibits malnutrition and systemic inflammation, both of which are closely linked to elevated surgical risks and postoperative complications. Exclusive enteral nutrition (EEN) is a standard nutritional therapy for CD, yet whether its core mechanism functions via nutritional support to improve body mass index (BMI) or via nutritional treatment to modulate inflammation, altering the C-reactive protein-to-albumin ratio (CAR) remains inadequately understood. Besides its related alterations in computed tomography enterography (CTE) parameters and laparoscopic surgery outcomes also remain important points. Methods: A cohort study was conducted at our Inflammatory Bowel Disease Center, enrolling 89 CD patients undergoing bowel resection. Those patients received EEN for 6 weeks preoperatively. All data were collected from a database. Moreover, cross-sectional imaging metrics were assessed by CTE parameters to further demonstrate the impact brought by EEN. Postoperative complications within 30 days were also recorded. Results: Preoperative EEN treatment significantly increased albumin levels (from 34.4 ± 4.1 g/L at baseline to 38.9 ± 4.5 g/L before surgery, p < 0.001), as well as improving inflammatory status via reduced CRP levels [from 23.0 (10.1, 36.5) mg/L at baseline to 2.8 (1.2, 5.0) mg/L before surgery, p < 0.001] and consequently decreased CAR (from 0.83 ± 0.79 g/L at baseline to 0.28 ± 0.75 g/L before surgery, p < 0.001). Patients receiving EEN also experienced fewer postoperative complications and a shorter postoperative length of stay. However, it was worth noting that BMI remained relative unchanged after EEN therapy (from 19.2 ± 3.4 kg/m 2 at baseline to 19.3 ± 3.1 kg/m 2 before surgery, p = 0.821). Conclusion: Preoperative EEN in CD patients effectively ameliorates the CAR without prominently affecting BMI. As a targeted anti-inflammatory strategy in the immediate preoperative period, EEN exerts its benefits primarily through rapid modulation of inflammation rather than weight gain.Keywords
This publication has 40 references indexed in Scilit:
- Exposure to polycyclic aromatic hydrocarbons and risk of abnormal liver function: The mediating role of C-reactive proteinEcotoxicology and Environmental Safety, 2025
- Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: A multicentre studyJournal of Cachexia, Sarcopenia and Muscle, 2023
- Surrogate Adiposity Markers and MortalityJAMA Network Open, 2023
- ESPEN guideline on Clinical Nutrition in inflammatory bowel diseaseClinical Nutrition, 2023
- Comprehensive comparison of the prognostic value of systemic inflammation biomarkers for cancer cachexia: a multicenter prospective studyInflammation Research, 2022
- The role of exclusive enteral nutrition in the pre-operative optimisation of adult patients with Crohn's disease. A systematic reviewClinical Nutrition ESPEN, 2021
- The role of exclusive enteral nutrition in the preoperative optimization of laparoscopic surgery for patients with Crohn's disease: A cohort studyInternational Journal of Surgery, 2019
- Association of Preoperative Narcotic Use With Postoperative Complications and Prolonged Length of Hospital Stay in Patients With Crohn DiseaseJAMA Surgery, 2016
- Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn’s disease: new prospective roles of CT enterographyLa radiologia medica, 2014
- Computed Tomography Enterography Detects Intestinal Wall Changes and Effects of Treatment in Patients With Crohn's DiseaseClinical Gastroenterology and Hepatology, 2011